BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 31843837)

  • 1. Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review.
    Leece P; Khorasheh T; Corace K; Strike C; Bayoumi AM; Taha S; Marks E; Pach B; Ahamad K; Grennell E; Holowaty M; Manson H; Straus SE
    BMJ Open; 2019 Dec; 9(12):e032285. PubMed ID: 31843837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review.
    Nixon LL; Marlinga JC; Hayden KA; Mrklas KJ
    Syst Rev; 2019 Jul; 8(1):186. PubMed ID: 31345258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review.
    Bozinoff N; Soobiah C; Rodak T; Bucago C; Kingston K; Klaiman M; Poynter B; Samuels G; Schoenfeld E; Shelton D; Kalocsai C
    BMJ Open; 2021 Sep; 11(9):e053207. PubMed ID: 34580102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to and facilitators for use of augmentative and alternative communication and voice restorative devices in the adult intensive care unit: a scoping review protocol.
    Istanboulian L; Rose L; Yunusova Y; Gorospe F; Dale C
    Syst Rev; 2019 Dec; 8(1):311. PubMed ID: 31810494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.
    Piske M; Thomson T; Krebs E; Hongdilokkul N; Bruneau J; Greenland S; Gustafson P; Karim ME; McCandless LC; Maclure M; Platt RW; Siebert U; SocĂ­as ME; Tsui JI; Wood E; Nosyk B
    BMJ Open; 2020 Sep; 10(9):e036102. PubMed ID: 32912944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.
    Mackey K; Veazie S; Anderson J; Bourne D; Peterson K
    J Gen Intern Med; 2020 Dec; 35(Suppl 3):954-963. PubMed ID: 33145687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoping review protocol to map the use of text-based two-way communication between patients and healthcare professionals after hospital discharge and identify facilitators and barriers to implementation.
    Jensen LWH; Ghaffari A; Dinesen BI; Rahbek O; Kold S
    BMJ Open; 2022 Sep; 12(9):e062087. PubMed ID: 36137634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
    Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
    BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for the health technology assessment of complex interventions: a protocol for a scoping review.
    Baghbanian A; Merlin T; Carter D; Wang S
    BMJ Open; 2020 Nov; 10(11):e039263. PubMed ID: 33257482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation of Buprenorphine to Facilitate Postoperative Pain Management for Patients on Buprenorphine Opioid Agonist Therapy.
    Mehta D; Thomas V; Johnson J; Scott B; Cortina S; Berger L
    Pain Physician; 2020 Mar; 23(2):E163-E174. PubMed ID: 32214293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: protocol for a qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Bourne A; Maher C; Mathieson S; Lin CC; O'Connor DA
    BMJ Open; 2019 Nov; 9(11):e034039. PubMed ID: 31722956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 20. Technology-Based Educational Approaches to Address Opioid Use Management by Advanced Practice Registered Nurses.
    Kameg BN; Mitchell A
    Issues Ment Health Nurs; 2020 Oct; 41(10):940-945. PubMed ID: 32584628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.